Table 4 Clinical characteristics of patients in association with CYP2C19
Characteristics | CYP2C19 Phenotype | ||||
|---|---|---|---|---|---|
N (92) | NM (49) | URM (1) | RM (30) | IM (10) | PM (2) |
Tumor seize | |||||
 ≤ 2 cm | 17 (17.52%) | 0 (00%) | 10 (10.30%) | 2 (2.06%) | 1 (1.03%) |
2 < size ≤ 5 cm | 26 (26.80%) | 1 (1.03%) | 17 (17.52%) | 7 (7.21%) | 1 (1.03%) |
 > 5 cm | 6 (6.18%) | 0 (00%) | 3 (3.09%) | 1 (1.03%) | 0 (00%) |
p-value | Ref | 0.68 | 0.90 | 0.25 | 0.82 |
Grade | |||||
I | 0 (00%) | 0 (00%) | 6 (6.18%) | 0 (00%) | 0 (00%) |
II | 36 (37.11%) | 0 (00%) | 18 (18.55%) | 7 (7.21%) | 1 (1.03%) |
III | 13 (13.40%) | 1 (1.03%) | 6 (6.18%) | 3 (3.09%) | 1 (1.03%) |
p-value | Ref | 0.15 | 0.87 | 0.44 | 0.35 |
Recurrence | |||||
No recurrence | 46 (47.42%) | 0 (00%) | 24 (24.74%) | 7 (7.21%) | 2 (2.06%) |
Locally | 2 (2.06%) | 1 (1.03%) | 3 (3.09%) | 2 (2.06%) | 0 (00%) |
Metastatic | 1 (1.03%) | 0 (00%) | 3 (3.09%) | 1 (1.03%) | 0 (00%) |
p-value | Ref | 0.27 | 0.22 | 0.17 | 0.46 |